510(k) Report

510(k) · Cleared

Recalled · 2007

Ces Ultra

K062284510(k) TraditionalCleared Apr 5, 2007241-day reviewClass II21 CFR 882.5800Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Neuro-Fitness, LLC · QJQ Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety

Cleared on Apr 5, 2007 as substantially equivalent to K895175 (Neurofitness, 1989) and 1 other predicate after a 241-day review. Its family tree reaches back 1 generation to 1988. 4 later devices descend from it. It has been recalled once.

Decided
Apr 5, 2007
Review
241 days
Class
Class II
Product code
QJQ
Recalls
1
Predicates
2

Its longest line of descent runs back 1 generation to K883812 (1988). 2 ancestors in all. 4 later devices descend from it, 3 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1989: 1 other ancestor2019: 1 descendant cleared2023: 1 descendant cleared2024: 1 descendant cleared2025: 1 descendant clearedK883812 · HP-1 (Healthpax) · Healthdirections, Inc. · 1988 · recalled1990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 3 descendants2 generations forward: 1 descendant K883812 · HP-1 (Healthpax) · Healthdirections, Inc. · 1988 · recalled0
  1. Root · 1 generation backK883812 HP-1 (Healthpax)Healthdirections, Inc. · 1988 · Recalled
  2. This deviceK062284 Ces UltraNeuro-Fitness, LLC · 2007
  3. Descendant · cites it directly · 1 of its ownK230826 Modius SleepNeurovalens, Ltd. · 2023
  4. Descendant · 2 generations on · 0 of its ownK252951 Genesis SleepNeurofield, Inc. · 2025
  5. Descendant · cites it directly · 0 of its ownK232253 Modius StressNeurovalens Limited · 2024
  6. Descendant · cites it directly · 0 of its ownK182311 CervellaInnovative Neurological Devices, LLC · 2019

Most influential descendants

Showing 4 of 4 · See all
  • K230826Modius SleepNeurovalens, Ltd. · 2023 · cites it directly1descendant
  • K252951Genesis SleepNeurofield, Inc. · 2025 · 2 generations on0descendants
  • K232253Modius StressNeurovalens Limited · 2024 · cites it directly0descendants
  • K182311CervellaInnovative Neurological Devices, LLC · 2019 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K883812HP-1 (Healthpax)Healthdirections, Inc.19881
0 (this device)K062284Ces UltraNeuro-Fitness, LLC2007—
+1K230826Modius SleepNeurovalens, Ltd.2023—
+2K252951Genesis SleepNeurofield, Inc.2025—
+1K232253Modius StressNeurovalens Limited2024—
+1K182311CervellaInnovative Neurological Devices, LLC2019—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198910

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201910
202310
202410
202510
FIG. 1 — Lineage of K062284, 1988–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QJQ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new QJQ device

  1. #1 K252951 Genesis Sleepscore 11.2 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K895175NF-1 Mindpeace
Summary page 1
…n Name: Stimulator, Cranial, Electrotherapy, a preamendment Class III device per 21 CFR § 882.5800 (JXK) Predicate Devices NF-1 Mindpeace CES, K895175, Neuro-Fitness, LLC HP-1 Healthpax CES, K883812, Healthdirections, Inc. Device Description The CES Ultra…
Neurofitness1989—
*K883812HP-1 (Healthpax)
Summary page 1
…reamendment Class III device per 21 CFR § 882.5800 (JXK) Predicate Devices NF-1 Mindpeace CES, K895175, Neuro-Fitness, LLC HP-1 Healthpax CES, K883812, Healthdirections, Inc. Device Description The CES Ultra is a device designed to deliver therapeutic electrical and Summary of…
Healthdirections, Inc.19881

What descends from it? (4)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K230826Modius SleepNeurovalens, Ltd.20231
K232253Modius StressNeurovalens Limited20240
K182311CervellaInnovative Neurological Devices, LLC20190

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Oct 29, 2007Not classifiedZ-0712-2008Finished device change controlNo FDA clearance for the .35Hz/.45Hz frequency option on device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K230826 (Neurovalens, Ltd., 2023) has gone furthest, with 1 descendant of its own.

How does its category compare?

All QJQ devices

QJQ Cranial Electrotherapy Stimulator To Treat Insomnia And/Or Anxiety: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · QJQ

1in 2025

2007: 12008: 12009: 12019: 12023: 12024: 12025: 1
2007high 1 (2007) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QJQ

Too few QJQ 510(k)s in any year since 2007 to give a median.

Recalls per year · QJQ

No recall names QJQ since 2007.

Adverse event reports per year · QJQ

39in 2023

2023: 39
2007high 39 (2023) · low 0 (2007)2025

MAUDE reports naming product code QJQ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20081—00
20091—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20191—00
20200—00
20210—00
20220—00
20231—039
20241—00
20251—00
20260—0—

What is it indicated for?

The CES UltraTM is indicated for the treatment of insomnia, depression, or anxiety.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K062284: Ces Ultra.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K062284

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026